Suneel Gupta, EVP Clinical Operations at Protagonist Therapeutics, Inc (PTGX), bought 30,000 shares at $5.13 ($154K) on 2019-12-03, disclosed to the SEC on 2019-12-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Several strong factors at once. The rarest rating we give.
| Filing → |